FDA Enforcement Class I Ongoing

CADD Administration Set, List Numbers: a) REF 21-7346-24; b) REF 21-7363-24

Recall: Z-0962-2023 · Reported February 8, 2023

Enforcement

Recall Number
Z-0962-2023
Event ID
91392
Classification
Class I
Status
Ongoing
Product Type
Devices
Firm
Smiths Medical ASD Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
February 8, 2023
Initiation Date
December 9, 2022
Classification Date
January 30, 2023
Address
6000 Nathan Ln N, N/A, Minneapolis, MN, 55442-1690, United States

Description

CADD Administration Set, List Numbers: a) REF 21-7346-24; b) REF 21-7363-24

Reason

There are two potential issues with CADD Infusion System Infusion Sets: (1) Lack of Delivery or Underdelivery related to Tubing Occlusion and (2) False "No Disposable Attached (NDA)" Alarms

Code Info

a) REF 21-7346-24: UDI/DI 35019517161957; Lot Numbers: 3776356 through 4320785; b) REF 21-7363-24: UDI/DI 3501951716196; Lot Numbers: 3773412 through 4334343;

Distribution

Worldwide Distribution: US (nationwide) and OUS countries of: CH, CA, ES, FR, AT, BE, IT, DK, NO, EE, DE, NL, AU, GB, SE, PL, SA, IN, IL, PT, CZ, IE, NZ, LU, SI, ZA, BM, SG, MQ, CL, LB, MY, HU, JP, TW, and CN

Quantity

1616714 units